273 related articles for article (PubMed ID: 38320881)
1. The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction-A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Lee VYJ; Houston L; Perkovic A; Barraclough JY; Sweeting A; Yu J; Fletcher RA; Arnott C
Heart Lung Circ; 2024 Feb; 33(2):197-208. PubMed ID: 38320881
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Exercise-based rehabilitation for heart failure.
Taylor RS; Sagar VA; Davies EJ; Briscoe S; Coats AJ; Dalal H; Lough F; Rees K; Singh S
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD003331. PubMed ID: 24771460
[TBL] [Abstract][Full Text] [Related]
4. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
Fukuta H; Goto T; Wakami K; Ohte N
Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
[TBL] [Abstract][Full Text] [Related]
5. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
[TBL] [Abstract][Full Text] [Related]
7. Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials involving 2624 patients.
Tanashat M; Manasrah A; Abouzid M
Eur J Clin Pharmacol; 2024 Jul; 80(7):951-963. PubMed ID: 38498097
[TBL] [Abstract][Full Text] [Related]
8. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
Kapelios CJ; Murrow JR; Nührenberg TG; Montoro Lopez MN
Heart Fail Rev; 2019 May; 24(3):367-377. PubMed ID: 30618017
[TBL] [Abstract][Full Text] [Related]
9. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Butler J; Shah SJ; Petrie MC; Borlaug BA; Abildstrøm SZ; Davies MJ; Hovingh GK; Kitzman DW; Møller DV; Verma S; Einfeldt MN; Lindegaard ML; Rasmussen S; Abhayaratna W; Ahmed FZ; Ben-Gal T; Chopra V; Ezekowitz JA; Fu M; Ito H; Lelonek M; Melenovský V; Merkely B; Núñez J; Perna E; Schou M; Senni M; Sharma K; van der Meer P; Von Lewinski D; Wolf D; Kosiborod MN;
Lancet; 2024 Apr; 403(10437):1635-1648. PubMed ID: 38599221
[TBL] [Abstract][Full Text] [Related]
10. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
[TBL] [Abstract][Full Text] [Related]
11. Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis.
Mei J; Xu H; Xu FQ; Ju JQ
Chin J Integr Med; 2019 Oct; 25(10):770-777. PubMed ID: 31127505
[TBL] [Abstract][Full Text] [Related]
12. Supervised exercise training in heart failure with preserved ejection fraction: A systematic review and meta-analysis of randomized controlled trials.
Sebastian SA; Padda I; Johal G
Curr Probl Cardiol; 2024 Apr; 49(4):102426. PubMed ID: 38311273
[TBL] [Abstract][Full Text] [Related]
13. Exercise Training in Heart failure with Preserved and Reduced Ejection Fraction: A Systematic Review and Meta-Analysis.
Edwards JJ; O'Driscoll JM
Sports Med Open; 2022 Jun; 8(1):76. PubMed ID: 35674912
[TBL] [Abstract][Full Text] [Related]
14. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
[TBL] [Abstract][Full Text] [Related]
15. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
Kitzman DW; Brubaker P; Morgan T; Haykowsky M; Hundley G; Kraus WE; Eggebeen J; Nicklas BJ
JAMA; 2016 Jan; 315(1):36-46. PubMed ID: 26746456
[TBL] [Abstract][Full Text] [Related]
16. High-intensity and moderate-intensity interval training in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
Lai P; Xue JH; Xie MJ; Ye JH; Yang N; Zhong YM; Liao YL
Medicine (Baltimore); 2023 Feb; 102(8):e33010. PubMed ID: 36827059
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis.
Chen Z; Zhao K; Xiao C; He Z; Liu S; Wu X; Shi S; Guo Y
Saudi Pharm J; 2022 Aug; 30(8):1079-1087. PubMed ID: 36164567
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]